PROGENY. Unmodified descendant from the MATERIAL, such as virus from virus, cell from cell, or organism from organism. UNMODIFIED DERIVATIVES: Substances created by the RECIPIENT which constitute an unmodified functional subunit or product expressed by the ORIGINAL MATERIAL. MODIFICATIONS: Substances created by the RECIPIENT which contain/incorporate the MATERIAL.
Appears in 2 contracts
Samples: Material Transfer Agreement (Mta), Material Transfer Agreement
PROGENY. Unmodified descendant from the MATERIAL, such as MATERIAL (for instance virus from virus, cell from cell, or organism from organism. ) UNMODIFIED DERIVATIVES: Substances created by the RECIPIENT which constitute constituting an unmodified functional subunit or product expressed by the ORIGINAL MATERIAL. MATERIAL MODIFICATIONS: Substances created by the RECIPIENT which contain/contain or incorporate the MATERIALMATERIAL The MATERIAL as listed in Appendix A is considered proprietary to Charité.
Appears in 1 contract
Samples: Material Transfer Agreement
PROGENY. Unmodified descendant from the MATERIALMaterial, such as virus from virus, cell from cell, or organism from organism. UNMODIFIED DERIVATIVESUnmodified Derivatives: Substances created by the RECIPIENT Recipient which constitute an unmodified functional subunit or product expressed by the ORIGINAL MATERIALOriginal Material. MODIFICATIONSSome examples include: subclones of unmodified cell lines, purified or fractionated subsets of the Original Material, proteins expressed by DNA/RNA supplied by the Provider, or monoclonal antibodies secreted by a hybridoma cell line. Modifications: Substances created by the RECIPIENT Recipient which contain/incorporate the MATERIALMaterial.
Appears in 1 contract